Sign up

Rice Hall James & Associates, LLC

$2.1B assets · 240 holdings · Q2 2026 · Filed 07 AUG 2026

About Rice Hall James & Associates, LLC’s 13F portfolio

Rice Hall James & Associates, LLC is an institutional investment manager that discloses its US-listed holdings each quarter through an SEC Form 13F filing. As of , Rice Hall James & Associates, LLC reported $2.1B across 240 US-listed positions (). Its largest position is LIGAND PHARMACEUTICALS INC (LGND) at 4.2% of the reported book, and its ten biggest holdings make up 24% of the portfolio. Browse every manager in the fund managers directory, or see the legendary investors we track on the superinvestors page.

$2.1B
Assets (13F)
#1,454
of 8,845 by size
240
Holdings
24%
Top-10 weight
124
Buys
118
Sells
Top holdings · Q2 2026
240 total
#StockPrice% of portfolioSharesValue
1
NASDAQ: LGND
LIGAND PHARMACEUTICALS INC
$286.94
−3.94%
4.2%
270K$85.4M
2
NASDAQ: ACIW
ACI WORLDWIDE INC
$50.50
−4.52%
2.5%
1.0M$50.6M
3
NYSE: ARLO
ARLO TECHNOLOGIES INC
$12.03
−0.25%
2.4%
3.7M$50.3M
4
NYSE: FN
FABRINET
$311.71
−2.61%
2.4%
88K$49.2M
5
NASDAQ: ESTA
ESTABLISHMENT LABS HLDGS INC
$69.61
−1.68%
2.3%
561K$48.1M
6
NYSE: XPO
XPO INC
$181.22
−3.67%
2.2%
225K$46.2M
7
NASDAQ: ZD
ZIFF DAVIS INC
$49.68
−2.28%
2.1%
821K$43.0M
8
NYSE: FOUR
SHIFT4 PMTS INC
$37.97
−6.91%
2.1%
874K$42.5M
9
NASDAQ: KNSA
KINIKSA PHARMACEUTICALS INTL
$93.54
−1.59%
1.9%
625K$40.0M
10
NASDAQ: ASND
ASCENDIS PHARMA A/S
$255.96
−5.32%
1.9%
149K$39.6M
11
NYSE: LRN
STRIDE INC
$76.20
−2.03%
1.8%
439K$37.9M
12
NYSE: PBH
PRESTIGE CONSMR HEALTHCARE I
$49.60
−2.02%
1.6%
690K$32.6M
13
NYSE: DFIN
DONNELLEY FINL SOLUTIONS INC
$65.41
−1.80%
1.6%
775K$32.5M
14
NASDAQ: ITRN
ITURAN LOCATION AND CONTROL
$46.52
−1.15%
1.4%
475K$29.0M
15
NASDAQ: MEDP
MEDPACE HLDGS INC
$633.98
−1.99%
1.4%
54K$28.7M
16
NYSE: AWI
ARMSTRONG WORLD INDS INC NEW
$169.03
−3.00%
1.4%
177K$28.4M
17
NYSE: GDDY
GODADDY INC
$102.15
−0.90%
1.4%
330K$28.1M
18
NYSE: BIRK
BIRKENSTOCK HOLDING PLC
$34.38
−4.71%
1.3%
630K$27.1M
19
NYSE: YOU
CLEAR SECURE INC
$54.94
+0.24%
1.3%
485K$27.0M
20
NYSE: NGVT
INGEVITY CORP
$55.96
−4.03%
1.3%
351K$26.2M
21
NYSE: WEX
WEX INC
$173.99
−4.11%
1.2%
179K$25.2M
22
NASDAQ: SRAD
SPORTRADAR GROUP AG
$12.02
−0.33%
1.2%
1.6M$23.9M
23
NASDAQ: LQDT
LIQUIDITY SVCS INC
$33.03
−24.88%
1.2%
608K$23.8M
24
NYSE: AGM
FEDERAL AGRIC MTG CORP
$164.06
−1.75%
1.1%
118K$23.5M
25
NASDAQ: BCRX
BIOCRYST PHARMACEUTICALS INC
$7.32
+0.27%
1.1%
2.3M$23.3M

Showing 1–25 of 240 positions on this page reported in this 13F.

Sector allocation
  • Healthcare33%
  • Technology28%
  • Industrials15%
  • Consumer Cyclical8.0%
  • Communication Services5.4%
  • Consumer Defensive3.2%
  • Financial Services2.9%
  • Basic Materials2.5%
  • Energy1.1%
Recent activity · vs 2026-03-31
Bought124
  • AddedACIWACI WORLDWIDE INC+0.3%$50.6M
  • AddedARLOARLO TECHNOLOGIES INC+2.0%$50.3M
  • AddedESTAESTABLISHMENT LABS HLDGS INC+2.2%$48.1M
  • AddedXPOXPO INC+0.3%$46.2M
  • AddedZDZIFF DAVIS INC+2.7%$43.0M
  • AddedFOURSHIFT4 PMTS INC+3.2%$42.5M
  • AddedKNSAKINIKSA PHARMACEUTICALS INTL+2.7%$40.0M
  • NewASNDASCENDIS PHARMA A/S—$39.6M
  • AddedLRNSTRIDE INC+0.1%$37.9M
  • AddedPBHPRESTIGE CONSMR HEALTHCARE I+32.2%$32.6M
Sold118
  • ReducedLGNDLIGAND PHARMACEUTICALS INC−4.8%$85.4M
  • ReducedFNFABRINET−17.2%$49.2M
  • ReducedDFINDONNELLEY FINL SOLUTIONS INC−0.6%$32.5M
  • ReducedITRNITURAN LOCATION AND CONTROL−10.6%$29.0M
  • ReducedYOUCLEAR SECURE INC−16.0%$27.0M
  • ReducedWEXWEX INC−0.9%$25.2M
  • ReducedRDWRRADWARE LTD−0.4%$21.0M
  • ReducedLKQLKQ CORP−1.0%$17.9M
  • ReducedOZKBANK OZK LITTLE ROCK ARK−0.1%$13.5M
  • ReducedMIRMMIRUM PHARMACEUTICALS INC−24.7%$13.0M
5%+ Beneficial Ownership Stakes · 1 passive (13G)

Companies where this manager has disclosed a stake of more than 5% of a class of shares, as reported to the SEC on Schedule 13D (activist) or 13G (passive). Figures are as disclosed in each filing — tap a date to open the source document.

#StockType% of classSharesFiled
1
CNTY
CENTURY CASINOS, INC.
13G5.1%1.5MFiled 09 JAN 2026

Showing all 1 disclosed stakes.

Reading Rice Hall James & Associates, LLC’s 13F portfolio

Rice Hall James & Associates, LLC’s $2.1B 13F book is spread across 240 reported positions and is broadly diversified — the ten largest names are just 24% of the portfolio. Spread this wide, no single position dominates the book. Its five largest positions are LGND, ACIW, ARLO, FN and ESTA, led by LIGAND PHARMACEUTICALS INC (LGND) at 4.2% of the portfolio. The heaviest sector exposure is Healthcare (33%), then Technology (28%).

What Rice Hall James & Associates, LLC changed last quarter

Between 2026-03-31 and Q2 2026, Rice Hall James & Associates, LLC was roughly balanced between buying and selling: it opened 14 new positions and added to 110 more, while trimming 101 and closing 17 outright. Against a 240-name book, that is moderate turnover, pointing to steady rotation within the portfolio. Its largest new or increased position was ACI WORLDWIDE INC (ACIW), and its biggest reduction was LIGAND PHARMACEUTICALS INC (LGND).

What a 13F does and doesn’t reveal

A 13F captures only Rice Hall James & Associates, LLC’s long positions in US-listed stocks at a single quarter-end, so it is best read as a lagged snapshot rather than a live portfolio. It won’t show shorts, cash, bonds, or holdings listed outside the US, and it never reveals the price paid or the reasoning behind a trade. The signal is in the pattern over time: which names Rice Hall James & Associates, LLC is building up, trimming, or exiting, and how concentrated the book stays from quarter to quarter.

Frequently asked questions

What is an SEC 13F filing?

A Form 13F is a report that every institutional investment manager with at least $100 million in US-listed securities must file with the SEC within 45 days of each quarter's end. It lists the manager's long positions in US-listed stocks and certain options, with the share count and market value of each. Rice Hall James & Associates, LLC's profile on this page is built directly from those filings.

How current is the 13F data on Rice Hall James & Associates, LLC's page?

It reflects Rice Hall James & Associates, LLC's most recently filed 13F, currently the quarter ending Q2 2026. Because managers have up to 45 days after a quarter closes to file, a 13F is always a slightly lagged view rather than a live portfolio. When Rice Hall James & Associates, LLC files its next quarterly report, this page refreshes automatically.

Can I see Rice Hall James & Associates, LLC's complete list of holdings?

This page highlights Rice Hall James & Associates, LLC's largest positions rather than all 240 names in the filing. The complete, position-by-position 13F is public and available from the SEC's EDGAR database under Rice Hall James & Associates, LLC's filings.

Does a 13F show everything Rice Hall James & Associates, LLC owns?

No. A 13F only covers long positions in US-listed stocks and certain options. It leaves out short positions, cash, bonds, commodities, foreign-listed stocks, and private holdings, so it is a partial view of Rice Hall James & Associates, LLC's book rather than its full strategy or total assets.

Is 13F data investment advice?

No. Everything here is educational. 13F positions are disclosed with a delay, cover only long US-listed holdings, and never explain why Rice Hall James & Associates, LLC made a trade or at what price. Treat it as a research lens, not a recommendation, and speak with a licensed financial advisor before making investment decisions.

Not investment advice. Holdings data comes from public SEC Form 13F filings, which are filed with a delay of up to 45 days and may be amended later. It describes historical, disclosed positions in US-listed securities only, meaning no shorts, cash, or foreign holdings, and it is not a recommendation. Always do your own research and speak with a licensed financial advisor before making investment decisions.